Home › Trial NCT04840758
Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer
- Trial IDNCT04840758
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorThe First Affiliated Hospital of Xiamen University
- Enrollment39
- Start date2021-06
- ConditionsMultiple Primary Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.